期刊文献+

持续高产型AmpC酶的产生与抗菌药物应用关系的研究 被引量:4

Relations Between Emergence of Constitutive High Expression AmpC β-Lactamase and Therapy of Antibiotics
原文传递
导出
摘要 目的了解抗菌药物对革兰阴性杆菌AmpC酶从诱导耐药型向持续高产型转变的影响作用。方法筛选携带诱导型菌株的患者作为研究对象,定期收集其感染标本,至转化为持续高产型,并对其菌种、基础疾病、期间抗菌药物使用种类及用量进行统计分析。结果 152株诱导型菌株中,68株转化为持续高产型,其中12株阴沟肠杆菌全部转化,转化率达100.0%;脑梗死患者的细菌更易转化(83.3%,OR=7.1);头孢菌素类(95.3%/64.6%)、多肽类(18.95%/15.5%)、青霉素类+β-内酰胺酶抑制剂(128.8%/276.0%)以及碳青酶烯类+β-内酰胺类(58.9%/82.3%)抗菌药物的用量对持续高产型AmpC酶的产生有着显著的影响(P<0.05),其中后两者剂量与转化率呈正相关,前两者呈负相关。结论大剂量青霉素类+β-内酰胺酶抑制剂和碳青酶烯类+β-内酰胺类抗菌药物可能会促进诱导型产酶菌株转变为持续高产型产酶菌株。 OBJECTIVE To investigate the influence of antibiotics to produce constitutive high expressed AmpC β-lactamases by Gram-negative bacilli.METHODS Selecting the bacilli which were resistant to cefoxitin and negative in three-dimention test from the patients with nosocomial infections.Collecting the same patients'samples for three-dimention test until they were positive.Recording the bacteria species,underlying diseases,the sorts and dosage of antibiotics.RESULTS Of 152 strains,68 was positive.Twelve strains of Enterobacter cloacae were all changed(100%).The bacteria from the cerebral patients were prone to turn into the constitutive high expression(P〈0.05),the positive rate was 83.3%(10/12,OR=7.1).used penicillins plus β-lactamase inhibitors(128.8/276.0)and carbapenem plus β-lactams(58.9/82.3)were positively related with the dosage of antibiotics,while cephalosporins(95.3/64.6)and peptide(18.9/15.5)were negatively related.CONCLUSIONS High dose penicillins+β-lactamase inhibitors and carbapenem+β-lactams may promote the producetion of durative high expressed AmpC β-lactamases.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第10期1351-1353,共3页 Chinese Journal of Nosocomiology
基金 上海市科委重点科研基金资助项目(054119509)
关键词 AMPC酶 持续高产型 革兰阴性杆菌 抗菌药物 AmpC Constitutive high expression Bacilli Antibiotics
  • 相关文献

参考文献12

  • 1Tan TT. "Future" threat of Gram-negative resistance in Singapore[J]. Ann Acad Med Sigapore,2008,37(10):884-890.
  • 2刘晶,多丽波.染色体介导的AmpC酶研究进展[J].国际检验医学杂志,2006,27(7):641-643. 被引量:13
  • 3Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: implications for antibi otic use [J]. Antimicrob Agents Chemother, 2008, 52 (3) : 995-1000.
  • 4Kim BN, Peleg AY, Lodise TP,et al. Management of meningitis due to antibiotic-resistant Acinetobacter species [J]. Lancet Infect Dis,2009,9(4):244-245.
  • 5Grobner S, Linke D, Schiitz W,et al. Emergence of carbapenem-non-susceptible extended-spectrum {beta}-lactamaseproducing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany[J]. J Med Microbiol, 2009, 58(Pt7) : 912-922.
  • 6段金菊,刘卓拉,张润梅,张瑞琴,杜娟,刘国栋,徐辉,康建邦.三维实验对产AmpC酶革兰阴性菌的检测及分析[J].中国药物与临床,2007,7(4):257-260. 被引量:10
  • 7Dobryan MT, David AB, Romeo H, et al. ampC Gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates[J]. FEMS Microbiol Lett, 2007,270 (2) 265-271.
  • 8Simona Bratu, David Landman, Jyoti Gupta, et al. Role of AmpD,OprF and penicillin-binding proteins in β-lactam resistanee in clinical isolates of Pseudomonas aeruginosa [J]. J Med Microbiol, 2007,56 (pt6): 809-814.
  • 9沈定树,周雪艳,袁远,徐玖飞,陈慧红,夏东,齐娟飞,陈东.肠杆菌诱导型AmpC酶对第三代和第四代头孢菌素的影响[J].中国微生态学杂志,2006,18(5):384-385. 被引量:9
  • 10明德松,吴一波,谢尊金.同时产超广谱β-内酰胺酶和AmpCβ-内酰胺酶菌的单独和联合药物敏感分析[J].中华医院感染学杂志,2004,14(5):489-491. 被引量:12

二级参考文献53

共引文献93

同被引文献24

  • 1张幸国,杜小幸,张嵘,魏泽庆,俞云松,陈亚岗,李兰娟.发现一株产KPC-2型碳青霉烯酶肺炎克雷伯菌[J].中华检验医学杂志,2006,29(9):824-826. 被引量:60
  • 2沈定霞,罗燕萍,曹敬荣,周光,杨喆.肺炎克雷伯菌和大肠埃希菌AmpCβ内酰胺酶的表型检测[J].临床检验杂志,2007,25(1):4-6. 被引量:37
  • 3储从家,孔繁林,吴惠玲.83例新生儿血培养阳性结果与临床分析[J].中国感染控制杂志,2007,6(4):253-254. 被引量:13
  • 4Verdet C,Benzerara Y.Emergence of DHA-1-producing Klebsiellaspp in the Parisian region:genetic organization of the ampC and ampR genes originating from Morganella morganii.Antimicrob Agents Chemother,2006,50(2):607-617.
  • 5Gonzlez Lpez JJ,Sabate M.Invivo reversion to the wildtye β-lactam resistance phenot-ype mediated by a plasmid carrying ampR and qnrA1 in Enterobacter cloacae.Ant imicrob Agents Chemother,2006,50(9):3175-3178.
  • 6NCCLS.Performance standards for antimicrobial susceptibility testing:Ninth informational supplement[S].Clincal Laboratory Standards Institute,1999:36-75.
  • 7杨锡强 易著文.儿科学[M] 第6版[M].北京:人民卫生出版社,2003.223-226.
  • 8Mohamudha PR,Harish BN,Parija SC.Molecular descrip-tion of plasmid-mediated AmpCβ-lactamase among nosocomi-al isolates of Escherichia coli&Klebsiella pneumoniae fromsix different hospitals in india[J].Indian J Med Res,2012,135:114-119.
  • 9Coudron PE,Moland ES,Thomoson KS.Occurrence and de-tection of AmpCβ-lactamases among Escherichia coli,Kleb-siella pneumoniae,and Proteus mirabilis isolates at a vetera-nis medical center[J].J Clin Microbiol,2000,38(5):1791.
  • 10Chakraborty U,Chakraborty BN,Basnet M,et al.Evaluationof ochrobactrum anthropi TRS-2and its talc based formula-tion for enhancement of growth of tea plants and managementof brown root rot disease[J].J Appl Microbiol,2009,107(2):625-634.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部